The Administrative Core (Core A) will provide programmatic direction, evaluation of scientific progress, facilitate interactions among investigators, and provide administrative support to the Program as a whole. The Program consists of four individual projects (Projects 1-4), and three Cores; Core A, the Quantitative and Functional HDL Core (Core B), and the Tissue and Imaging Core (Core C). The Principal Investigator, Dr. Karin Bornfeldt, will be the Program Director and Dr. Alan Chait will be Co-Director. The Administrative Core will be responsible for the day-to-day administrative and fiscal support, and will provide financial reports and oversight of the four Projects and Cores B and C. Other functions of Core A include organizing monthly lab meetings and an annual retreat to provide coordination and communication within the Program, organizing peer review of trainees' fellowship applications to promote their careers, and maintaining a website for data sharing and communication within the Program Project and outside investigators. A Program Project Management Committee consisting of the Project Leaders will be responsible for planning and dealing with local issues. An Internal Advisory Committee will evaluate the Program Project on an annual basis to assess progress and direction. The Administrative Core will also be responsible for evaluation of the entire program by outside consultants and by an External Review Committee.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL092969-56
Application #
9472372
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Chen, Jue
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
56
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Basu, Debapriya; Huggins, Lesley-Ann; Scerbo, Diego et al. (2018) Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition. Arterioscler Thromb Vasc Biol 38:2207-2216
Subramanian, Savitha; Goodspeed, Leela; Wang, Shari et al. (2018) Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. Int J Mol Sci 19:
Goldberg, Ira J; Reue, Karen; Abumrad, Nada A et al. (2018) Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop. Circulation 138:305-315
He, Yi; Kothari, Vishal; Bornfeldt, Karin E (2018) High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus. Arterioscler Thromb Vasc Biol 38:e10-e16
Pourmousa, Mohsen; Song, Hyun D; He, Yi et al. (2018) Tertiary structure of apolipoprotein A-I in nascent high-density lipoproteins. Proc Natl Acad Sci U S A 115:5163-5168
Kim, KyeongJin; Goldberg, Ira J; Graham, Mark J et al. (2018) ?-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor. Cell Metab 27:816-827.e4
Tannock, Lisa R; De Beer, Maria C; Ji, Ailing et al. (2018) Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein. J Lipid Res 59:339-347
Wall, Valerie Z; Barnhart, Shelley; Kanter, Jenny E et al. (2018) Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome. JCI Insight 3:
Kanter, Jenny E; Kramer, Farah; Barnhart, Shelley et al. (2018) A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome. Diabetes 67:946-959
Yuan, Chujun; Hu, Jiyuan; Parathath, Saj et al. (2018) Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice. Diabetes 67:1880-1891

Showing the most recent 10 out of 136 publications